Safety of lacosamide in children with refractory partial epilepsy.

about

The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity.Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children.

P2860

Q47716238-1D66B2B4-45C6-48F5-80B7-F249650D8E65 Q55500128-5CBB44AA-BBEA-4873-87CB-E5FCDB99FDD1

P2860

Safety of lacosamide in children with refractory partial epilepsy.

Item

http://www.wikidata.org/entity/Q36162002

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Safety of lacosamide in children with refractory partial epilepsy.

@ast

Safety of lacosamide in children with refractory partial epilepsy.

@en

type

Item

label

Safety of lacosamide in children with refractory partial epilepsy.

@ast

Safety of lacosamide in children with refractory partial epilepsy.

@en

prefLabel

Safety of lacosamide in children with refractory partial epilepsy.

@ast

Safety of lacosamide in children with refractory partial epilepsy.

@en

P1476

Safety of lacosamide in children with refractory partial epilepsy.

@en

P2093

D K Suresh

http://www.w3.org/2001/XMLSchema#string

Ismail Pasha

http://www.w3.org/2001/XMLSchema#string

Mahesh Kamate

http://www.w3.org/2001/XMLSchema#string

P2860

Early identification of refractory epilepsy

Use of lacosamide in children with refractory epilepsy

Evolving treatment strategies for epilepsy.

In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation

Seeking a mechanism of action for the novel anticonvulsant lacosamide.

Lacosamide: a review of preclinical properties.

Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures.

Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.

Development of new antiepileptic drugs: challenges, incentives, and recent advances.

New concepts in classification of the epilepsies: entering the 21st century.

P304

556-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSPS.2015.01.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271388823

http://www.w3.org/2001/XMLSchema#string

P698

26594123

http://www.w3.org/2001/XMLSchema#string

P932

4605901

http://www.w3.org/2001/XMLSchema#string

Safety of lacosamide in children with refractory partial epilepsy.

about

P2860

P2860

Safety of lacosamide in children with refractory partial epilepsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932